New hope for teens with schizophrenia in major drug trial
Disease control
Recruiting now
This study is testing if a medication called cariprazine can help control symptoms of schizophrenia in teenagers aged 13 to 17. Over 330 participants will be randomly assigned to receive either the real medication or a placebo (a pill with no medicine) for 6 weeks. Researchers wi…
Phase: PHASE3 • Sponsor: Gedeon Richter Plc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC